๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The affinity adsorptive recovery of an infectious Herpes Simplex Virus vaccine

โœ Scribed by R. S. O'Keeffe; M. D. Johnston; N. K. H. Slater


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
642 KB
Volume
62
Category
Article
ISSN
0006-3592

No coin nor oath required. For personal study only.

โœฆ Synopsis


The chromatographic purification of a recombinant Herpes Simplex Virus (type 2) from salt-and heparin-released harvests of infected complementing Vero (CR2) cells is addressed. Functionalized matrices and process operating conditions are identified that provide adequate virus titres in eluates that are significantly reduced in CR2 cell protein and DNA and possess a low level of HSV-2 protein. Virus from diluted salt-released harvests (0.14 M NaCl) was not appreciably adsorbed onto either heparin-Sepharose or Cellufine-heparin matrices but was virtually completely adsorbed onto Cellufine-sulfate and heparin-HP matrices. Virus was recovered by either a linear salt gradient elution (0.14-2 M NaCl) or by a single-step elution with 1.5 M NaCl in phosphate buffer. Recoveries of infectious virus with step elution were 21% and 89%, respectively, for these matrices. Virus from undiluted salt-released harvest (0.8 M NaCl) was substantially adsorbed onto Cellufine-sulfate gel (44% adsorption) and completely adsorbed onto heparin-HP matrices. This virus was recovered with high yield by either gradient or step elution with phosphate-buffered saline. Finally, heparin-harvested virus was fed directly to these matrices and quantitatively adsorbed. The virus could be completely recovered from the heparin-HP matrix with 1.5 M NaCl buffer to provide a purified preparation containing only 0.05 pg protein/pfu and 1.2 ร— 10 -4 pg DNA/pfu.


๐Ÿ“œ SIMILAR VOLUMES


The primary production of an infectious
โœ R. O'Keeffe; M. D. Johnston; N. K. H. Slater ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 514 KB

The production and extracellular release of a recombinant Herpes Simplex Virus (type 2) from monolayers of infected complementing Vero cells (CR2) are addressed. Growth and virus production conditions are identified that provide adequate virus titers with cell seeding densities and viral multiplicit

From virus to vaccine: Recombinant mamma
โœ Laurence A. Lasky ๐Ÿ“‚ Article ๐Ÿ“… 1990 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 337 KB

## Abstract The use of mammalian cells as substrates for the production of various vaccines is a timeโ€honored procedure. With the advent of recombinant DNA technology, various investigators soon realized that these techniques could be applied to mammalian cells to convert them to reliable, safe pro

Herpes simplex virus hepatitis: An analy
โœ John P. Norvell; Andres T. Blei; Borko D. Jovanovic; Josh Levitsky ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 98 KB

Hepatitis is a rare complication of herpes simplex virus (HSV), often leading to acute liver failure (ALF), liver transplantation (LT), and/or death. Our aim was to identify variables associated with either survival or progression (death/LT), based on an analysis of cases in the literature and our i

A preclinical assessment of the safety a
โœ Gillian Langford; Anthony Dayan; Seppo Yla-Herttuala; David Eckland ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 476 KB

## Abstract ## Background Cereproยฎ (sitimagene ceradenovec) is an adenoviral vector containing herpes simplex virus thymidine kinase gene (HSVโ€tk), which is being developed for the treatment of highโ€grade glioma with oral ganciclovir (GCV). The nonclinical safety and biodistribution of Cereproยฎ we